What does CUSIP 98420N105 represent in this 13F holders report?

CUSIP 98420N105 is the security identifier for XENE - Xenon Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held XENE - Xenon Pharmaceuticals Inc. - Common Stock in Q4 2019?

66 institutional investors reported XENE - Xenon Pharmaceuticals Inc. - Common Stock for Q4 2019. Use the holders table for investor-level position and value details.

Xenon Pharmaceuticals Inc. - Common Stock (XENE)

CUSIP: 98420N105

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / Common Stock
Total 13F shares: 18,704,750
Total 13F value: $245,218,634
Share change: +1,615,130
SEC-reported price per share: $13.11
Number of holders: 66
Value change: +$22,437,621
Number of buys: 30
Number of sells: 16
Shares outstanding: 95,032,800

Security key

98420N105

Report period

Q4 2019

Institutions

Top holders

XENE full security history Ownership snapshot Full 13F holder table Xenon Pharmaceuticals Inc. SEC filings Xenon Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Avoro Capital Advisors LLC

Disclosed value leader

Avoro Capital Advisors LLC

Comparable rows

15/15

Latest evidence

30 Sep 2019

13F Lead comparable stake: 2.5% Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 2.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.

Comparable ownership Top 5

Avoro Capital Advisors LLC 2.5%

BVF INC/IL 1.8%

ADAGE CAPITAL PARTNERS GP, L.L.C. 1.4%

EVENTIDE ASSET MANAGEMENT, LLC 1.3%

Capital International Investors 1.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Avoro Capital Advisors LLC	13F Company 13F	2.5%	$21,624,000 2,400,000 shares	—	30 Sep 2019
BVF INC/IL	13F Company 13F	1.8%	$15,692,000 1,741,600 shares	—	30 Sep 2019
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	1.4%	$11,713,000 1,300,000 shares	—	30 Sep 2019
EVENTIDE ASSET MANAGEMENT, LLC	13F Company 13F	1.3%	$11,480,000 1,274,100 shares	—	30 Sep 2019
Capital International Investors	13F Company 13F	1.1%	$9,512,000 1,055,726 shares	—	30 Sep 2019
Capital World Investors	13F Company 13F	1%	$8,681,000 963,500 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

18,704,750

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 value	Q4 2019 value	Value change	Value Chg %